-
Aldeyra Therapeutics Inc (NASDAQ: ALDX) surged
57.9 percent to $6.63. Aldeyra Therapeutics disclosed 'positive' results from dry eye disease Phase 2a clinical trial.
-
Aethlon Medical, Inc. (NASDAQ: AEMD) shares
climbed 50.6 percent to $3.01 after the company disclosed Expedited Access Pathway designation from the FDA to accelerate US
access to Hemopurifier.
-
Quotient Ltd (NASDAQ: QTNT) shares gained 28.1
percent to $4.75 after the company reports results from latest MosaiQ performance evaluation studies prior to commencing
verification and validation studies.
-
SAExploration Holdings, Inc. (NASDAQ: SAEX)
shares rose 20 percent to $2.87.
-
Inovalon Holdings Inc (NASDAQ: INOV) shares
surged 17.6 percent to $17.23. Morgan Stanley upgraded Inovalon Holdings from Underweight to Equal-Weight and raised the price
target from $9.00 to $14.00.
-
Forterra Inc (NASDAQ: FRTA) shares rose 15.8
percent to $4.90.
-
Akari Therapeutics PLC (ADR) (NASDAQ: AKTX)
shares surged 10 percent to $5.29.
-
Citius Pharmaceuticals Inc (NASDAQ: CTXR) shares
rose 9.5 percent to $3.50.
-
Baozun Inc (ADR) (NASDAQ: BZUN) shares climbed
8.3 percent to $34.82.
-
Pier 1 Imports Inc (NYSE: PIR) shares rose 6.8
percent to $4.64.
-
MasTec, Inc. (NYSE: MTZ) climbed 6.1 percent to
$43.40. Deutsche Bank upgraded MasTec from Hold to Buy.
-
Comerica Incorporated (NYSE: CMA) rose 3.8 percent
to $69.29. Piper Jaffray upgraded Comerica from Neutral to Overweight.
-
Alcoa Corp (NYSE: AA) surged 3.2 percent to $44.99.
Deutsche Bank upgraded Alcoa from Hold to Buy.
-
Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA) gained 3.1 percent to $19.07 after surging 19.35 percent on Monday. The
company reported the sale of PARAGARD to CooperSurgical for $1.1 billion in cash.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.